TREATMENT OF LATE-ONSET NEURODEGENERATIVE DISEASES IN HETEROZYGOUS NPC1 GENE MUTATION CARRIERS

App. 19/534,297 Filed 2026-02-09 Docketed New Case - Ready for Examination

DEUTERATED ANALOGS OF ACETYL-LEUCINE

App. 18/921,779 Filed 2024-10-21 Non Final Action Mailed

BRANCHED-CHAIN AMINO ACID DERIVATIVES TO TREAT DISEASE

App. 18/539,781 Filed 2023-12-14 Patented Case

BETAHISTINE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND A MONOAMINE OXIDASE INHIBITOR, FOR USE IN THE TREATMENT OR PREVENTION OF ONE OR MORE SYMPTOMS OF VERTIGO IN A SUBJECT

App. 18/320,761 Filed 2023-05-19 Patented Case

THE COMBINATION OF ACETYL LEUCINE AND 4-AMINOPYRIDINE OR ACETAZOLAMIDE FOR TREATING ATAXIA

App. 17/999,598 Filed 2022-11-22 Response to Non-Final Office Action Entered and Forwarded to Examiner

TREATMENT OF LATE-ONSET NEURODEGENERATIVE DISEASES IN HETEROZYGOUS NPC1 GENE MUTATION CARRIERS

App. 17/758,759 Filed 2022-07-13 Patented Case

COMBINATION THERAPY WITH ACETYL-LEUCINE AND MIGLUSTAT

App. 17/623,313 Filed 2021-12-28 Patented Case

LEUCINE, ACETYL LEUCINE, AND RELATED ANALOGS FOR TREATING DISEASE

App. 17/435,784 Filed 2021-09-02 Non Final Action Mailed

BETAHISTINE, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND A MONOAMINE OXIDASE INHIBITOR, FOR USE IN THE TREATMENT OR PREVENTION OF ONE OR MORE SYMPTOMS OF VERTIGO IN A SUBJECT

App. 17/396,064 Filed 2021-08-06 Patented Case

DEUTERATED ANALOGS OF ACETYL-LEUCINE

App. 17/311,240 Filed 2021-06-04 Patented Case